Natco Pharma is a Hyderabad-based pharma. For more information, please read https://www.thehealthsite.com/topics/natco/ Experts believe that this case will set a ...

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case.

As it expands its business across new therapeutic areas such as Hepatitis C and cardio-diabetology, the Street believes Natco is well-placed to counter macro headwinds facing the pharma sector.